Article List

WPRIM Management System> DCMS> Blood Research> 2018> 53> 2

Volume: 53 Issue: 2

1. Retraction.	Page:182—182
2. Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia.	Page:180—181
3. Acetate moderately attenuates the generation of neutrophil extracellular traps.	Page:177—180
4. Primary CNS lymphoma: latest updates and a 10-year monocenter experience.	Page:174—177
5. Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia.	Page:172—174
6. Microangiopathic hemolytic anemia as initial presentation of recurrent colon cancer.	Page:167—169
7. Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center.	Page:166—167
8. The first concurrent diagnosis of acute symptomatic Babesiosis and chronic myeloid leukemia in a healthy young adult.	Page:163—166
9. Synchronous hairy cell leukemia and chronic lymphocytic leukemia: a case report with a brief review of literature.	Page:160—163
10. The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML).	Page:152—159
11. Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin.	Page:145—151
12. Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis.	Page:138—144
13. Clinical characteristics and outcomes of thrombotic microangiopathy in Malaysia.	Page:130—137
14. Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents.	Page:123—129
15. Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent.	Page:117—122
16. Clinical characteristics and treatment courses for cytomegalovirus-associated thrombocytopenia in immunocompetent children after neonatal period.	Page:110—116
17. Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma.	Page:105—109
18. Del(5q) myelodysplastic syndrome combined with pure red cell aplasia.	Page:104—104
19. Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation.	Page:103—103
20. Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As₂O₃) and all-trans retinoic acid (ATRA).	Page:169—172
21. Megakaryoblasts in a newborn with Down syndrome.	Page:102—102
22. The ubiquitous parasite: leishmaniasis in an elderly man.	Page:101—101
23. How much progress has Blood Research made since the change of the journal title in 2013.	Page:95—100